TM4SF18: A Potential Drug Target and Biomarker for Transmembrane 4-L Layer 18

Target Name: TM4SF18

NCBI ID: G116441

TM4SF18

TM4SF18: A Potential Drug Target and Biomarker for Transmembrane 4-L Layer 18

Introduction

The Transmembrane 4 (TM4) superfamily is a growing body of membrane proteins that play a significant role in various physiological processes. TM4 proteins are involved in various cellular processes, including intracellular signaling, cell adhesion, and neurotransmission. The TM4 superfamily includes six members, TM4SF18, TM4SF19, TM4SF20, TM4SF21, TM4SF22, and TM4SF23. TM4SF18 is one of the TM4SF proteins that has received significant attention due to its unique structure and function.

In this article, we will discuss TM4SF18, its potential drug targets, and its role as a biomarker in various diseases.

Structure and Function

TM4SF18 is a 18-kDa protein that consists of a transmembrane domain and an intracellular domain. The transmembrane domain is characterized by a single transmembrane 伪-helix and a 尾-sheet. The intracellular domain is composed of a hinge-like structure that is involved in the formation of a complex with other proteins.

TM4SF18 is involved in various cellular processes, including intracellular signaling, cell adhesion, and neurotransmission. It is highly expressed in various tissues, including brain, heart, and pancreas. TM4SF18 has been shown to play a role in intracellular signaling, specifically in the regulation of the Wnt signaling pathway.

TM4SF18 has also been shown to be involved in cell adhesion. TM4SF18 has been shown to interact with various adhesion molecules, including cadherins and integrins, and to regulate their activity. This suggests that TM4SF18 may play a role in the regulation of cell-cell adhesion, which is critical for various cellular processes, including tissue repair and regeneration.

TM4SF18 has also been shown to be involved in neurotransmission. TM4SF18 has been shown to interact with various neurotransmitter receptors, including dopamine, GABA, and glutamate. This suggests that TM4SF18 may play a role in the regulation of neurotransmission, which is critical for the function of the nervous system.

Potential Drug Targets

TM4SF18 has been shown to be involved in various cellular processes, including intracellular signaling, cell adhesion, and neurotransmission. As a result, TM4SF18 may be a potential drug target.

One potential drug target for TM4SF18 is the use of small molecules that can modulate its activity. For example, small molecules that can inhibit the activity of TM4SF18 can be used to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

Another potential drug target for TM4SF18 is the use of antibodies that can specifically bind to TM4SF18 and modulate its activity. This approach can be used to treat diseases where specific antibodies can be used to target and modulate the activity of TM4SF18.

Biomarker

TM4SF18 has also been shown to be involved in various cellular processes, including intracellular signaling, cell adhesion, and neurotransmission. This suggests that TM4SF18 may be a potential biomarker for various diseases.

One approach to use TM4SF18 as a biomarker is to use it as a protein expression level to diagnose diseases. For example, if TM4SF18 is expressed at higher levels in tissues of diseases, such

Protein Name: Transmembrane 4 L Six Family Member 18

The "TM4SF18 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TM4SF18 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets